RT Journal Article SR Electronic T1 Integrating psychosocial variables and societal diversity in epidemic models for predicting COVID-19 transmission dynamics JF medRxiv FD Cold Spring Harbor Laboratory Press SP 2020.08.12.20173252 DO 10.1101/2020.08.12.20173252 A1 VK Jirsa A1 S Petkoski A1 H Wang A1 M Woodman A1 J Fousek A1 C Betsch A1 L Felgendreff A1 R Böhm A1 L Lilleholt A1 I Zettler A1 SM Faber A1 K Shen A1 AR McIntosh YR 2020 UL http://medrxiv.org/content/early/2020/08/14/2020.08.12.20173252.abstract AB During the current COVID-19 pandemic, governments must make decisions based on a variety of information including estimations of infection spread, health care capacity, economic and psychosocial considerations. The disparate validity of current short-term forecasts of these factors is a major challenge to governments. By causally linking an established epidemiological spread model with dynamically evolving psychosocial variables, using Bayesian inference we estimate the strength and direction of these interactions for German and Danish data of disease spread, human mobility, and psychosocial factors based on the serial cross-sectional COVID-19 Snapshot Monitoring (COSMO; N = 16,981). We demonstrate that the strength of cumulative influence of psychosocial variables on infection rates is of a similar magnitude as the influence of physical distancing. We further show that the efficacy of political interventions to contain the disease strongly depends on societal diversity, in particular group-specific sensitivity to affective risk perception. As a consequence, the model may assist in quantifying the effect and timing of interventions, forecasting future scenarios, and differentiating the impact on diverse groups as a function of their societal organization. Importantly, the careful handling of societal factors, including support to the more vulnerable groups, adds another direct instrument to the battery of political interventions fighting epidemic spread.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research was supported by European Union Horizon 2020 research and innovation programme under grant agreement No. 945539 (SGA3) Human Brain Project. Germany COVID-19 Snapshot Monitoring (COSMO) is a joint project of the University of Erfurt (Cornelia Betsch [PI], Lars Korn, Philipp Sprengholz, Philipp Schmid, Lisa Felgendreff, Sarah Eitze), the Robert Koch Institute (RKI; Lothar H. Wieler, Patrick Schmich), the Federal Centre for Health Education (BZgA; Heidrun Thaiss, Freia De Bock), the Leibniz Centre for Psychological Information and Documentation (ZPID; Michael Bosnjak), the Science Media Center (SMC; Volker Stollorz), the Bernhard Nocht Institute for Tropical Medicine (BNITM; Michael Ramharter), and the Yale Institute for Global Health (Saad Omer); funding: BZgA, RKI, ZPID, University of Erfurt (no grant number). Denmark COSMO is funded by the Faculty of Social Sciences, University of Copenhagen (to RB and IZ), and Lundbeck Foundation, grant no. R349-2020-592 (to RB).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics approval was requested from the University of Erfurt review board. Details are here: https://www.psycharchives.org/handle/20.500.12034/2386. Research is also oriented on the ethical standards of AAPOR (https://www.aapor.org/Standards-Ethics/AAPOR-Code-of-Ethics.aspx) and APA (https://www.apa.org/ethics/code/).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll simulated data are available upon request. https://projekte.uni-erfurt.de/cosmo2020/cosmo-analysis.html